Difference between revisions of "Team:Technion Israel/Project/Overview"
Line 5: | Line 5: | ||
<link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Technion/CSS?action=raw&ctype=text/css" /> | <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Technion/CSS?action=raw&ctype=text/css" /> | ||
+ | <link rel="stylesheet" type="text/css" href="https://2015.igem.org/Template:Technion/navbar/css?action=raw&ctype=text/css" /> | ||
<style type="text/css"> | <style type="text/css"> | ||
body { | body { | ||
Line 14: | Line 15: | ||
<body> | <body> | ||
− | < | + | <!-------------------------------------nav-bar----------------------------------------------> |
− | + | <div class="nav_menu"> | |
− | + | ||
− | + | <a href="https://2015.igem.org/Team:Technion_Israel"> | |
− | + | <img src="https://static.igem.org/mediawiki/2015/c/c1/Team_Technion_Navbar_Home.png" alt="Home" id="nav_home" /></a> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | < | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | <div class="main_buttons"> | |
− | <div class=" | + | <div id="project" class="main_button">Project</div> |
− | + | <div id="Lab_Notebook" class="main_button">Lab Notebook</div> | |
− | + | <div id="Human_Practices" class="main_button">Human Practices</div> | |
− | + | <div id="Judging_Criteria" class="main_button">Judging Criteria</div> | |
− | + | <div id="Team" class="main_button">Team</div> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</div> | </div> | ||
− | <!-------------------------------------- | + | <nav> |
+ | <div id="Team_Links" class="main_links"> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Team/About_Us">About Us</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Attributions">Attributions</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Team/Sponsors">Sponsors</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Team/gallery">Gallery</a> | ||
+ | </div> | ||
+ | <div id="Judging_Criteria_Links" class="main_links"> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Parts">Parts</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Judging_Criteria/Achievements">Achievements</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Collaborations">Collaborations</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Design">Design</a> | ||
+ | </div> | ||
+ | <div id="Human_Practices_Links" class="main_links"> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Practices">Practices</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Practices/safety">Safety</a> | ||
+ | </div> | ||
+ | <div id="Lab_Notebook_Links" class="main_links"> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Lab_Notebook/Overview">Overview</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Lab_Notebook/Protocols">Protocols</a> | ||
+ | </div> | ||
+ | <div id="project_Links" class="main_links"> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Project/Overview">Overview</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Project/Bacillus">Bacillus</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Project/E_Coli">E.Coli</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Project/NADPH">NADPH</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Project/Comb">Comb</a> | ||
+ | <a href="https://2015.igem.org/Team:Technion_Israel/Modeling">Modeling</a> | ||
+ | </div> | ||
+ | </nav> | ||
+ | </div> | ||
+ | <!-------------------------------------nav-bar-end------------------------------------------> | ||
<div class="content"> | <div class="content"> | ||
Line 147: | Line 94: | ||
<script type="text/javascript" src="jquery-1.8.0.min.js"></script> | <script type="text/javascript" src="jquery-1.8.0.min.js"></script> | ||
− | <script type="text/javascript" src="https://2015.igem.org/Template:Technion/ | + | <script type="text/javascript" src="https://2015.igem.org/Template:Technion/navbar/javascript? |
action=raw&ctype=text/javascript"></script> | action=raw&ctype=text/javascript"></script> | ||
</body> | </body> | ||
</html> | </html> |
Revision as of 09:27, 11 September 2015
Hello! Welcome to our temporary wiki page!
Hair loss affects roughly 61 million people in the United States. More than 95% of hair thinning in men is attributed to male pattern baldness, or androgenetic alopecia. The hair loss product market is a multi-billion dollar market: in the United States alone, this market’s annual revenue is 7 billion dollars, with 3.5% annual growth rate from 2007 to 2012, yet a sufficient solution has yet to be made available. The trigger for androgenetic alopecia is believed to be dihydrotestosterone (DHT), a derivative of testosterone. This summer, we are engineering Bacillus Subtilis, a model organism for a bacterium found naturally on the scalp, to secrete 3?-hydroxysteroid dehydrogenase (3-?-HSD). This enzyme reduces DHT to a non-steroidically active compound, using NADPH and NADH as cofactors.
Our project consists of 3 main parts: 3-?-HSD secretion by the bacterium, engineered bacterium for NADPH overproduction, and a comb as a tool to create a user-friendly experience. By synchronizing these parts, we hope to be able to show convincing evidence of DHT breakdown, providing a promising platform for treatment of male pattern baldness!